SpineJournal.gr

New High Viscosity Cement for the treatment of vertebral compression fractures

KALAMAZOO, Mich., March 1 (HSMN NewsFeed) — Stryker Interventional Spine today announced the U.S. launch of VertaPlex® HV. VertaPlex HV is a high viscosity bone cement for use in treating vertebral compression fractures. (more…)

WILMINGTON, N.C., Jan. 7, 2010 — (HSMN NewsFeed) — TranS1 Inc. (Nasdaq:TSON ), a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine, is pleased to announce the appointment of Ken Reali as President and Chief Operating Officer. (more…)

KALAMAZOO, Mich., Oct. 20 /PRNewswire-FirstCall/ — Stryker Corporation (NYSE: SYK – News) reported operating results for the quarter ended September 30, 2009 as follows:
Third Quarter Highlights (more…)

KALAMAZOO, Mich., Sept. 1 /PRNewswire-FirstCall/ — Stryker Corporation (NYSE: SYK) announces senior level organizational changes, effective today.

Lonny J. Carpenter, currently Group President, Instruments and Medical, assumes the newly created position of Group President, Global Quality and Operations, reporting to Stephen P. MacMillan, President and Chief Executive Officer. In this role, Mr. Carpenter will be responsible for setting and executing company-wide quality, manufacturing, procurement and logistics strategies. Mr. Carpenter has been with Stryker for 20 years, holding leadership positions of increasing responsibility across our global manufacturing network prior to his most recent role as Group President of the Instruments and Medical group.

Michael P. Mogul, currently President, Orthopaedics, is promoted to Group President, Orthopaedics and a corporate officer, reporting to Mr. MacMillan. In this role, Mr. Mogul will assume additional leadership responsibilities for the global Trauma and CMF franchises in addition to his current responsibilities. Mr. Mogul has been with Stryker for 20 years, holding various leadership positions within the Instruments, EMEA and Orthopaedics divisions.

Timothy J. Scannell, currently Group President, Spine and Endoscopy, becomes Group President, MedSurg and Spine, reporting to Mr. MacMillan. In this role, Mr. Scannell will assume additional leadership responsibilities for the Instruments and Medical divisions. Mr. Scannell has been with Stryker for 19 years, holding various leadership positions within the Endoscopy, Biotech and Spine divisions.

Stryker Corporation is one of the world’s leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company’s products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit www.stryker.com.

SOURCE Stryker Corporation

Katherine A. Owen, Vice President, Strategy and Investor Relations of Stryker Corporation, +1-269-385-2600